HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Expert Panel Set To Make Final Formaldehyde Recommendations Sept. 27

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic Ingredient Review Expert Panel could issue a final safety assessment for formaldehyde and methylene glycol at its Sept. 27 meeting.

You may also be interested in...



OSHA Fines Hair-Smoothing Outfits For Not Warning Of Formaldehyde Risks

The Occupational Safety and Health Administration says four Florida-based businesses committed 16 health violations by failing to protect employees and users from exposure hazards related to formaldehyde in heated hair-smoothing products.

FDA Warning To “Formaldehyde-Free” Brazilian Blowout Cites High Methylene Glycol Levels

In an Aug. 22 warning letter, FDA says hair-smoothing product Brazilian Blowout Acai Professional Smoothing Solution is adulterated and misbranded as it contains high levels of methylene glycol, which converts to formaldehyde when heated, while product labeling states the product is free of formaldehyde.

Hair Smoothing Reps Expect New Data Will Exonerate Formaldehyde

Additional data regarding the safety of formaldehyde and methylene glycol in professional hair-smoothing products could help change the Cosmetic Ingredient Review Expert Panel’s tentative “unsafe” assessment for the ingredients, representatives of the keratin smoothing industry suggest.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel